Addex Therapeutics analyst ratings
Addex Therapeutics analyst ratings
While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a maintained with a price target of $21.00 to $15.00. The current price Addex Therapeutics (ADXN) is trading at is $3.68, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 05/31/2022 | 307.61% | HC Wainwright & Co. | $21 → $15 | Maintains | Buy |
| 02/11/2022 | 470.65% | HC Wainwright & Co. | $28 → $21 | Maintains | Buy |
| 04/21/2021 | 660.87% | HC Wainwright & Co. | → $28 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 05/31/2022 | 307.61% | HC Wainwright & Co. | 21 美元 → 15 美元 | 维护 | 买 |
| 2022 年 11 月 2 日 | 470.65% | HC Wainwright & Co. | 28 美元 → 21 美元 | 维护 | 买 |
| 2021 年 4 月 21 日 | 660.87% | HC Wainwright & Co. | → 28 美元 | 启动覆盖范围开启 | → 购买 |
Addex Therapeutics Questions & Answers
Addex Therapeutics 问题与解答
The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on May 31, 2022. The analyst firm set a price target for $15.00 expecting ADXN to rise to within 12 months (a possible 307.61% upside). 2 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年5月31日公布了Addex Therapeutics（纳斯达克股票代码：ADXN）的最新目标股价。该分析公司将目标股价定为15.00美元，预计ADXN将在12个月内升至12个月内（可能上涨307.61％）。去年有两家分析公司公布了评级。
The latest analyst rating for Addex Therapeutics (NASDAQ: ADXN) was provided by HC Wainwright & Co., and Addex Therapeutics maintained their buy rating.
HC Wainwright & Co. 提供了Addex Therapeutics（纳斯达克股票代码：ADXN）的最新分析师评级，Addex Therapeutics维持买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addex Therapeutics was filed on May 31, 2022 so you should expect the next rating to be made available sometime around May 31, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Addex Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Addex Therapeutics的最新评级是在2022年5月31日公布的，因此您应该预计下一个评级将在2023年5月31日左右公布。
While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a maintained with a price target of $21.00 to $15.00. The current price Addex Therapeutics (ADXN) is trading at is $3.68, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Addex Therapeutics（ADXN）评级维持不变，目标股价为21.00美元至15.00美元。Addex Therapeutics（ADXN）目前的交易价格为3.68美元，超出了分析师的预期区间。
